Kinvard Bio antibiotics represent a groundbreaking advancement in the fight against drug-resistant infections, a pressing global health concern exacerbated by antimicrobial resistance.This innovative startup, co-founded by Ben Tresco and Kelvin Wu, is harnessing the power of new antibiotics designed to target the bacterial ribosome, a critical yet previously underexplored area in antibiotic development.
